Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease

키워드

참고문헌 (59)

1. Yoshida S, "Selective cyclo-oxygenase 2 inhibitor in patients with aspirininduced asthma", J Allergy Clin Immunol, 106, pp.1201~1202 (2000)
2. Szczeklik A, "Natural history of aspirin-induced asthma, in AIANE investigators, in European Network on Aspirin-Induced Asthma", Eur Respir J, 16, pp.432~436 (2000)
3. Hedman J, "Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study", Int J Epidemiol, 28, pp.717~722 (1999)
4. Vally H, "The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients", Thorax, 57, pp.569~574 (2002)
5. Mascia K, "TENOR Study Group. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma", J Allergy Clin Immunol, 116, pp.970~975 (2005)
6. Palikhe NS, "Association of three sets of high-affinity IgE receptor (FcepsilonR1) polymorphisms with aspirin-intolerant asthma", Respir Med, 102, pp.1132~1139 (2008)
7. Sladek K, "Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma", Eur Respir J, 6, pp.391~399 (1993)
8. Park HS, "Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients", Clin Exp Allergy, 25, pp.38~40 (1995)
9. Kowalski ML, "Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest)", Allergy, 60, pp.1139~1145 (2005)
10. Gaber F, "Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma", Thorax, 63, pp.1076~1082 (2008)
11. Hamad AM, "Aspirin-induced asthma: clinical aspects, pathogenesis and management", Drugs, 64, pp.2417~2432 (2004)
12. Lee TH, "Leukotriene (E4): perspective on the forgotten mediator", J Allergy Clin Immunol, 124, pp.417~421 (2009)
13. Kupczyk M, "Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysineaspirin nasal challenge in vivo model", Allergy, 64, pp.1746~1752 (2009)
14. Hui Y, "Cysteinyl leukotriene receptors", Biochem Pharmacol, 64, pp.1549~1557 (2002)
15. Capra V, "Molecular and functional aspects of human cysteinyl leukotriene receptors", Pharmacol Res, 50, pp.1~11 (2004)
16. Ciana P, "The orphan receptor GPR17 identified as a new dual uracil nucleotides", cysteinyl-leukotrienes receptor, 2006, pp.25, 4615~4627
17. Peters-Golden M, "Leukotrienes", N Engl J Med, 357, pp.1841~1854 (2007)
18. Sousa AR, "Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis", N Engl J Med, 347, pp.1493~1499 (2002)
19. Szczeklik A, "Safety of a specific COX-2 inhibitor in aspirininduced asthma", Clin Exp Allergy, 31, pp.219~225 (2001)
20. Picado C, "Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics", Am J Respir Crit Care Med, 160, pp.291~296 (1999)
21. Morgan T, "Aspirininduced COX-2 overexpression in monocytes of aspirin-intolerant patients", Int Arch Allergy Immunol, 149, pp.378~384 (2009)
22. Picado C, "Aspirinintolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation", Eur Respir J, 2, pp.127~129 (1989)
23. Kowalski ML, "Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients", Am J Respir Crit Care Med, 161, pp.391~398 (2000)
24. Chambers LS, "PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells", Am J Physiol Lung Cell Mol Physiol, 285, pp.L619~L627 (2003)
25. Taniguchi M, "Hyperleukotrieneuria in patients with allergic and inflammatory disease", Allergol Int, 57, pp.313~320 (2008)
26. Palikhe NS, "Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease", Allergy (2009)
27. Szczeklik A, "J Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics", Am J Respir Crit Care Med, 154, pp.1608~1614 (1996)
28. Dahlen SH, "Novel mechanisms involving new and old eicosanoids in bronchial inflammation, in XXVII Congress of the European Academy of Allergy and Clinical Immunology", XXVII Congress of the European Academy of Allergy and Clinical Immunology, pp.6~10 (2009)
29. Feltenmark S, "Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells", Proc Natl Acad Sci U S A, 통권 : 105, pp.680~685 (2008)
30. Lee JY, "Role of staphylococcal superantigen-specific IGE antibodies in aspirinintolerant asthma", Allergy Asthma Proc, 통권 : 27, pp.341~346 (2006)
31. Suh YJ, "Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma", Clin Exp Allergy, 34, pp.1270~1275 (2004)
32. Szczeklik A, "Aspirin-induced asthma as a viral disease", Clin Allergy, 18, pp.15~20 (1988)
33. Okada H, "Anti-asthma effect of an antiviral drug, acyclovir: a clinical case and experimental study", Clin Exp Allergy, 27, pp.431~437 (1997)
34. Szczeklik A, "Altered distribution of IgG subclasses in aspirin-induced asthma: high IgG4, low IgG1", Clin Exp Allergy, 22, pp.283~287 (1992)
35. Choi JH, "HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population", J Allergy Clin Immunol, 113, pp.562~564 (2004)
36. Sanak M, "Enhanced expression of the leukotriene C (4) synthase due to overactive transcription of an allelic variant associated with aspirinintolerant asthma", Am J Respir Cell Mol Biol, 23, pp.290~296 (2000)
37. Van Sambeek R, "flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States", J Allergy Clin Immunol, 160, pp.72~76 (2000)
38. Choi JH, "Lack of an association between a newly identified promoter polymorphism (-1702G > A) of the leukotriene C4 synthase gene and aspirin-intolerant asthma in a Korean population", Tohoku J Exp Med, 208, pp.49~56 (2006)
39. Sayers I, "Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5- lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a caucasian population", Clin Exp Allergy, 33, pp.1103~1110 (2003)
40. Kim SH, "Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness", Allergy, 60, pp.760~765 (2005)
41. Kim SH, "Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males", Clin Exp Allergy, 36, pp.433~439 (2006)
42. Kim SH, "CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients", Pharmacogenomics, 8, pp.1143~1150 (2007)
43. Park JS, "Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics", Pharmacogenet, 15, pp.483~492 (2005)
44. Kim SH, "A polymorphism of MS4A2 (- 109T > C) encoding the betachain of the high-affinity immunoglobulin E receptor (FcepsilonR1beta) is associated with a susceptibility to aspirin-intolerant asthma", Clin Exp Allergy, 36, pp.877~883 (2006)
45. Kim SH, "Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis", Allergy, 64, pp.1221~1225 (2009)
46. Kim SH, "Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma", Clin Exp Allergy, 35, pp.585~590 (2005)
47. Akahoshi M, "Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma", Hum Genet, 117, pp.16~26 (2005)
48. Kim SH, "Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma", Pharmacogenet Genomics, 17, pp.295~304 (2007)
49. Kim TH, "Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics", Clin Exp Allergy, 38, pp.1727~1737 (2008)
50. Kim SH, "Association of four-locus gene interaction with aspirin-intolerant asthma in Korean asthmatics", J Clin Immunol, 28, pp.336~342 (2008)
51. Soto-Quiros ME, "Practical handling of the asthma based on the control of the disease: Update of GINA guidelines", Anales de Paediatr, 68, pp.317~319 (2008)
52. Obase Y, "Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients", Chest, 121, pp.143~150 (2002)
53. Israel E, "The protective effects of leukotriene modifiers in aspirininduced asthma", Postgrad Med, 108, pp.40~44 (2000)
54. Mygind N, "Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy", Allergy, 55, pp.11~15 (2000)
55. Berges-Gimeno MP, "The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions", Clin Exp Allergy, 32, pp.1491~1496 (2002)
56. Nayak A, "A review of montelukast in the treatment of asthma and allergic rhinitis", Expert Opin Pharmacother, 5, pp.679~686 (2004)
57. Lee JY, "Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirinexacerbated respiratory disease", J Allergy Clin Immunol, 119, pp.157~164 (2007)
58. Juergens UR, "Inhibition of monocyte leukotriene B4 production after aspirin desensitization", J Allergy Clin Immunol, 96, pp.148~156 (1995)
59. Arm JP, "Leukotriene receptors and aspirin sensitivity", N Engl J Med, 347, pp.1524~1526 (2002)

관련 논문AI추천